Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Environmental toxins and toxic metals in autoimmune diseases: Sex differences, hormonal influences, and immune dysregulation.

Autoimmunity reviews·2025
Same author

Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications.

Autoimmunity reviews·2025
Same author

Corrigendum to "Cadmium sulfide-induced toxicity in the cortex and cerebellum: <i>In vitro</i> and <i>in vivo</i> studies" [Toxicol. Rep. 7 (2020) 637-648].

Toxicology reports·2024
Same author

Editorial: Linking environmental exposure to toxicants and chronic disease.

Frontiers in toxicology·2024
Same author

Metal-induced autoimmunity in neurological disorders: A review of current understanding and future directions.

Autoimmunity reviews·2023
Same author

Cerebrolysin Alleviating Effect on Glutamate-Mediated Neuroinflammation Via Glutamate Transporters and Oxidative Stress.

Journal of molecular neuroscience : MN·2022

Related Experiment Video

Updated: Jul 19, 2026

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

HIV neurotoxicity: potential therapeutic interventions.

David R Wallace1

  • 1Department of Pharmacology and Physiology and Department of Forensic Sciences, Center for Health Sciences, Oklahoma State University, Tulsa, OK 74107-1898, USA.

Journal of Biomedicine & Biotechnology
|October 19, 2006
PubMed
Summary

Human Immunodeficiency Virus type 1 (HIV-1) infection causes neurological deficits, including motor and cognitive impairments. This review summarizes current theories on HIV neurotoxicity and potential therapies to prevent neuronal damage.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Related Experiment Videos

Last Updated: Jul 19, 2026

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Area of Science:

  • Neuroscience
  • Virology
  • Immunology

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) infection is associated with significant neurological deficits.
  • AIDS-related dementia (HAD) is a debilitating syndrome characterized by cognitive and motor impairments.
  • Neuronal loss and cortical atrophy are observed in advanced stages of HIV infection.

Purpose of the Study:

  • To review current understanding of HIV-1 neurotoxicity mechanisms.
  • To summarize recent research on HIV-related neuronal degeneration.
  • To explore potential therapeutic interventions for HIV-associated neurological deficits.

Main Methods:

  • Review of existing literature on HIV neurotoxicity.
  • Synthesis of current theories on pathogenesis.
  • Identification of potential therapeutic targets.

Main Results:

  • HIV-1 neurotoxicity involves complex direct and indirect mechanisms.
  • Key implicated factors include HIV proteins (Tat, gp120), glutamatergic system, nitric oxide, calcium, oxidative stress, apoptosis, and microglia.
  • Understanding these mechanisms is crucial for developing effective treatments.

Conclusions:

  • HIV-1 infection poses a significant threat to neurological health.
  • Further research into neurotoxic pathways is essential.
  • Targeted therapeutic strategies may prevent or mitigate HIV-associated cognitive and motor deficits.